%0 Letter
%T [Tislelizumab in second line treatment for advanced oesophageal squamous cell carcinoma after previous treatment with platinum-based therapy].
%A Duval J
%A Zaanan A
%J Bull Cancer
%V 111
%N 7
%D 2024 Jul-Aug 20
%M 38772846
%F 1.318
%R 10.1016/j.bulcan.2024.03.006